Peripheral sympathetic control during dobutamine infusion (original) (raw)
Effects of short-term administration of dobutamine on left ventricular performance, exercise capacity, norepinephrine levels, and lymphocyte adrenergic receptor density in congestive heart failure
M. Drici
Cardiovascular Drugs and Therapy, 1990
View PDFchevron_right
Evaluation of cardiac beta 1-adrenergic sensitivity with dobutamine in healthy volunteers
P. Thomare
British Journal of Clinical Pharmacology, 1995
View PDFchevron_right
Hemodynamic effect of dobutamine in patients with severe heart failure
Nasim Akhtar
American Journal of Cardiology, 1975
View PDFchevron_right
P1.15 Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients refractory to dobutamine: Direct evidence from sympathetic neural recording
Fabien Despas
Autonomic Neuroscience, 2009
View PDFchevron_right
Dobutamine effects on spontaneous variability of ventricular arrhythmias in patients with severe chronic heart failure: the Italian Multicenter Study.
Paolo Emilio Puddu
Italian heart journal: …, 2004
View PDFchevron_right
Effect of dobutamine on plasma potassium in congestive heart failure secondary to idiopathic or ischemic cardiomyopathy
Irvin Goldenberg
The American Journal of Cardiology, 1989
View PDFchevron_right
Cardiovascular effects of dobutamine in severe congestive heart failure
Joseph Andy
American Heart Journal, 1977
View PDFchevron_right
Differing autonomic responses to dobutamine stress in the presence and absence of myocardial ischaemia
Richard Sutton
The Journal of Physiology, 2015
View PDFchevron_right
Effects of dopamine on left ventricular afterload and contractile state in heart failure: Relation to the activation of beta1-adrenoceptors and dopamine receptors
Kenneth Borow
Journal of The American College of Cardiology, 1988
View PDFchevron_right
The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy
R. Altschuld
American Heart Journal, 1983
View PDFchevron_right
Haemodynamic response during low-dose dobutamine infusion in patients with chronic systolic heart failure: Comparison of echocardiographic and invasive measurements
Christian Tuxen
2013
View PDFchevron_right
Sympathetic Stimulations by Exercise-Stress Testing and by Dobutamine Infusion Induce Similar Changes in Heart Rate Variability in Patients with Chronic Heart Failure
Andrew Coats
Clinical Science, 1995
View PDFchevron_right
Role of the beta2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride
Kenneth Borow
The American Journal of Cardiology, 1988
View PDFchevron_right
Short- and long-term dobutamine treatment in chronic ischemic heart failure
Nili Zafrir
Clinical Cardiology, 1987
View PDFchevron_right
Measurement of Sympathetic Nervous System Activity in Heart Failure: The Role of Norepinephrine Kinetics
Murray Esler
2000
View PDFchevron_right
Influence of dobutamine and dopamine on hemodynamics and plasma concentrations of noradrenaline and renin in patients with low cardiac output following acute myocardial infarction
Ursula Gundert-remy
European Journal of Clinical Pharmacology, 1980
View PDFchevron_right
The Role of Dobutamine Dose on the Cardiac Parameters
Rabindra Nath Das
Cardiovascular Pharmacology: Open Access, 2018
View PDFchevron_right
Dobutamine in chronic ischemic heart failure: Alterations in left ventricular function and coronary hemodynamics
Thomas Ports
The American Journal of Cardiology, 1981
View PDFchevron_right
Effects of dopaminergic agents on cardiac and renal function in normal man and in patients with congestive heart failure
Kong Lie
International Journal of Cardiology, 1992
View PDFchevron_right
Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure
Uri Elkayam
American Heart Journal, 1989
View PDFchevron_right
Heterogeneous myocardial catecholamine concentrations in patients with congestive heart failure
Irvin Goldenberg
American Journal of Cardiology, 1987
View PDFchevron_right
Effects of dobutamine on left ventricular performance and myocardial metabolic demands in patients with ischemic heart disease
M. Vandormael
Clinical Cardiology, 1984
View PDFchevron_right
Dobutamine increases cardiac output of the total artificial heart. Implications for vascular contribution of inotropic agents to augmented ventricular function
Philip Binkley
Circulation, 1991
View PDFchevron_right
Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure
Joseph Gage
Circulation, 1986
View PDFchevron_right
Effects of a single, 24-hour, low-dose intravenous dobutamine infusion on left ventricular myocardial performance index in congestive heart failure: A prospective, nonrandomized study
Mehmet Emin Korkmaz
Current Therapeutic Research, 2005
View PDFchevron_right
Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy
Doron Aronson, Uri Elkayam
The American Journal of Cardiology, 2001
View PDFchevron_right
Relationship Between Myocardial Beta-Adrenergic Sensitivity and Heart Rate Variability
Jean-louis Montastruc, J. Sénard
Annals of Noninvasive Electrocardiology, 2000
View PDFchevron_right
Nonselective Versus Selective -Adrenergic Receptor Blockade in Congestive Heart Failure: Differential Effects on Sympathetic Activity
Susanna Mak
Circulation, 2001
View PDFchevron_right
Effect of dobutamine on left ventricular relaxation and filling phase in patients with ischemic heart disease and preserved systolic function
Roberto Zeppellini
Cardiovascular Drugs and Therapy, 1993
View PDFchevron_right
Adverse consequences of high sympathetic nervous activity in the failing human heart
Murray Esler
Journal of the American College of Cardiology, 1995
View PDFchevron_right
Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure
m Iacona
American Heart Journal, 1985
View PDFchevron_right
Acute -Blockade Increases Muscle Sympathetic Activity and Modifies Its Frequency Distribution
Raffaello Furlan, Alberto Porta, Tomaso Gnecchi-Ruscone
Circulation, 2004
View PDFchevron_right
Adrenergic Nervous System in Heart Failure: Pathophysiology and Therapy
Giuseppe Rengo
Circulation Research, 2013
View PDFchevron_right
Effects of chronic dobutamine administration on hearts of normal and hypertensive rats
Ashwani Malhotra
Circulation Research, 1988
View PDFchevron_right
Mitigation of beta 1- and/or beta 2-adrenoceptor function in human heart failure
Martin Michel
British Journal of Clinical Pharmacology, 1990
View PDFchevron_right